Evidence map›Paper›PMID 27498869›Full record

ArticleCell reports2016

A Distinct Lung-Interstitium-Resident Memory CD8(+) T Cell Subset Confers Enhanced Protection to Lower Respiratory Tract Infection.

Pavlo Gilchuk, Timothy M Hill, Clifford Guy, Sean R McMaster, Kelli L Boyd, Whitney A Rabacal, Pengcheng Lu, Yu Shyr, Jacob E Kohlmeier, Eric Sebzda and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. CD8MedComm · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Pavlo GilchukDepartment of Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN 37232, USA; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Timothy M HillDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Clifford GuyDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Sean R McMasterDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Kelli L BoydDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Whitney A RabacalDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Pengcheng LuVanderbilt Technologies for Advanced Genomics Analyses and Research Design, Vanderbilt University School of Medicine, Nashville, TN 37232, USA; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Yu ShyrVanderbilt Technologies for Advanced Genomics Analyses and Research Design, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Jacob E KohlmeierDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Eric SebzdaDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Sebastian JoyceDepartment of Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN 37232, USA; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Electronic address: sebastian.joyce@vanderbilt.edu.
Vanderbilt University · USEmory University · USSt. Jude Children's Research Hospital · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI MAY, JAMES M. · 1985 to 2008
$38.3M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Host Determinants of Human Metapneumovirus Immunity and PathogenesisR01AI085062 · NIAID · VANDERBILT UNIVERSITY · PI John V. Williams · 2010 to 2026
$5.6M
Interdisciplinary Training in Rheumatic DiseasesT32AR059039 · NIAMS · VANDERBILT UNIVERSITY · PI Tracy Minan Frech, AMY S MAJOR · 2010 to 2026
$4.3M
MOLECULAR BASIS OF CDLDL AND NATURAL T CELL FUNCTIONR01AI042284 · NIAID · VANDERBILT UNIVERSITY · PI JOYCE, SEBASTIAN · 1998 to 2013
$3.1M
MOLECULAR IMMUNOLOGY OF MINOR HISTOCOMPATIBILITY ANTIGENR01HL054977 · NHLBI · VANDERBILT UNIVERSITY · PI JOYCE, SEBASTIAN · 1995 to 2009
$2.6M
Establishment, maintenance, and consequences of asymmetric cell division in T cellsR01AI123322 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 2017 to 2021
$2.2M
Molecular Basis of iNKT Cell Ontogeny and FunctionR01AI061721 · NIAID · VANDERBILT UNIVERSITY · PI JOYCE, SEBASTIAN · 2006 to 2010
$2.1M
BLRD VA I01 BX001444NCI NIH HHS P30 CA021765NCI NIH HHS P30 CA068485NCRR NIH HHS M01 RR000095NHLBI NIH HHS F30 HL118954NHLBI NIH HHS R01 HL054977NHLBI NIH HHS R01 HL121139NHLBI NIH HHS R01 HL122559NIAID NIH HHS N01 AI040079NIAID NIH HHS R01 AI042284NIAID NIH HHS R01 AI061721NIAID NIH HHS R01 AI085062NIAID NIH HHS R01 AI123322NIAID NIH HHS R21 AI042284NIAMS NIH HHS T32 AR059039NIDDK NIH HHS P30 DK058404NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM008169
6 · The paper itself

Abstract

The nature and anatomic location of the protective memory CD8(+) T cell subset induced by intranasal vaccination remain poorly understood. We developed a vaccination model to assess the anatomic location of protective memory CD8(+) T cells and their role in lower airway infections. Memory CD8(+) T cells elicited by local intranasal, but not systemic, vaccination with an engineered non-replicative CD8(+) T cell-targeted antigen confer enhanced protection to a lethal respiratory viral challenge. This protection depends on a distinct CXCR3(LO) resident memory CD8(+) T (Trm) cell population that preferentially localizes to the pulmonary interstitium. Because they are positioned close to the mucosa, where infection occurs, interstitial Trm cells act before inflammation can recruit circulating memory CD8(+) T cells into the lung tissue. This results in a local protective immune response as early as 1 day post-infection. Hence, vaccine strategies that induce lung interstitial Trm cells may confer better protection against respiratory pathogens.

Indexed as

Immunologic MemoryAdministration, IntranasalAmino Acid SequenceAnimalsAntigens, ViralBody WeightCD8-Positive T-LymphocytesGene ExpressionImmunity, MucosalImmunophenotypingLungMiceMice, TransgenicReceptors, CXCR3Respiratory Tract InfectionsVaccinationAntigens, ViralCxcr3 protein, mouseReceptors, CXCR3Viral Vaccines

Identifiers

PMID27498869
PMCPMC5021515
OpenAlexW2480583798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.